{
    "2018-04-16": [
        [
            {
                "time": "",
                "original_text": "抗癌概念股有哪些？抗癌概念股龙头一览",
                "features": {
                    "keywords": [
                        "抗癌",
                        "概念股",
                        "龙头"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-A评级]医药行业每周观点：关注一季度业绩超预期及白马股短期调整带来投资机会 重点推荐千金药业、葵花药业、万孚生物",
                "features": {
                    "keywords": [
                        "医药",
                        "业绩",
                        "超预期",
                        "白马股",
                        "调整",
                        "千金药业",
                        "葵花药业",
                        "万孚生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]恒瑞医药(600276)年报点评：财务表现稳健向好 创新集群持续向前",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "年报",
                        "财务表现",
                        "创新集群"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-A评级]糖尿病系列报告：从国内外临床用药代差看中国降糖药市场发展趋势",
                "features": {
                    "keywords": [
                        "糖尿病",
                        "临床用药",
                        "降糖药",
                        "市场趋势"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药行业周报：药店集中度提升和处方外流有望加速",
                "features": {
                    "keywords": [
                        "医药",
                        "药店",
                        "集中度",
                        "处方外流",
                        "加速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "458亿资金争夺20股：主力资金重点出击5股(名单)",
                "features": {
                    "keywords": [
                        "资金",
                        "争夺",
                        "主力资金",
                        "重点出击"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：市场调整是医药板块逐步布局的好时机",
                "features": {
                    "keywords": [
                        "医药生物",
                        "市场调整",
                        "布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：2017年业绩超预期 增持评级",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "2017",
                        "业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：研发投入加大推进创新药品上市 买入评级",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "研发投入",
                        "创新药品",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "陆股通净流入28.31亿 白酒龙头股受追捧",
                "features": {
                    "keywords": [
                        "陆股通",
                        "净流入",
                        "白酒",
                        "龙头股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "开盘：两市小幅低开 海南板块大涨5%",
                "features": {
                    "keywords": [
                        "开盘",
                        "两市",
                        "低开",
                        "海南板块"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]恒瑞医药(600276)年报点评：2017业绩略超预期 期待重磅创新药品种上市",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "年报",
                        "2017",
                        "业绩",
                        "创新药品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：2017年净利同比增24% 70倍PE压力山大",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "2017",
                        "净利",
                        "PE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "北上资金单周净买入创新高，创业板获持续加仓",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "创业板",
                        "加仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药:销售改革驱动增长明显,创新药即将进入收获期",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "销售改革",
                        "增长",
                        "创新药",
                        "收获期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}